强生(JNJ)

搜索文档
Trump claims Tylenol use during pregnancy linked to autism, suggests Leucovorin as treatment
MINT· 2025-09-22 21:15
US President Donald Trump on Monday (September 22) suggested a connection between the use of over-the-counter pain medication Tylenol during pregnancy and the development of autism, a claim that many medical experts dispute.“Taking Tylenol is not good. I'll say it. Not good,” Trump said. "For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary."He added, “You shouldn't give the child a Tylenol every time he gets a shot.”The President also ment ...
10 Stocks and ETFs That Could Be Good for the Middle Class
Yahoo Finance· 2025-09-22 19:17
According to the National Financial Educators Council, a lack of financial literacy cost Americans an average of $1,015 per person and over $243 billion collectively in 2024. On a separate note, research from Gallup found that 62% of Americans own stocks. While investing is becoming more popular, it’s evident that there’s plenty of confusion surrounding the topic. If you’re a regular retail investor with a middle-class income, you likely want to take investing seriously but may not be sure about where to ...
Tylenol-maker Kenvue’s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials
Fortune· 2025-09-22 18:58
A pending announcement from the Trump administration linking pain relief drug acetaminophen with autism has stirred investor anxiety in the drug’s primary producer. The share price of Kenvue, the parent company of Tylenol, is down more than 5% on Monday following President Donald Trump’s comments that acetaminophen is “a very big factor” for the risk of autism. Kenvue’s stock is down 25% over the last six months as the company has worked—against investor sentiment—to navigate repeated claims about the pain ...
J&J Adds $63B in Market Cap in 3 Months: Time to Buy the Stock?
ZACKS· 2025-09-22 14:21
Key Takeaways JNJ has gained 17.7% in three months, adding nearly $63B in market cap.Innovative Medicine sales rose 2.4% despite Stelara's patent loss.MedTech sales grew 6.1%, boosted by Abiomed, Shockwave and new launches.Johnson & Johnson (JNJ) has delivered a strong run over the past three months, with shares up 17.7% and nearly $63 billion in market capitalization added. The stock’s technicals support this momentum. It has been trading consistently above its 50-day and 200-day moving averages since mid- ...
Charlie Kirk Memorial: Trump Vows To Award Medal Of Freedom
Forbes· 2025-09-21 23:41
ToplinePresident Donald Trump said he would award Charlie Kirk the Presidential Medal of Freedom posthumously as he eulogized the late activist at a memorial Sunday, following speeches from Kirk’s wife Erika and many members of the Trump administration to tens of thousands of supporters.President Donald Trump stands with Erika Kirk, Charlie Kirk's widow, at his memorial service in Arizona.AFP via Getty ImagesKey FactsTrump echoed earlier speakers, calling Kirk an “evangelist for American liberty” and a “mar ...
10 Best Pharma Stocks to Buy According to Billionaires
Insider Monkey· 2025-09-21 13:29
In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Recently, President Trump wrote letters to 17 major pharmaceutical firms outlining the actions they should take to bring the prices of prescription pharmaceuticals in the United States down to “most favored nation” (MFN) levels by September 29.President Trump’s demand for “binding commitments” to lower drug prices sent pharmaceutical companies “scrambling to respond,” according to a CNBC report on August ...
Johnson & Johnson’s Myeloma Breakthrough and Homan Bribery Allegations Surface
Stock Market News· 2025-09-21 04:08
Key TakeawaysJohnson & Johnson (JNJ) announced a 100% overall response rate (ORR) for its combination therapy of Tecvayli and Darzalex in newly diagnosed multiple myeloma patients, marking a significant advancement in cancer treatment.The promising results from the Phase 1/2 study suggest a potential new frontline treatment option for multiple myeloma, a difficult-to-treat blood cancer.Separately, a report from MSNBC alleges that former high-ranking official Homan sought a $50,000 payment from individuals b ...
Johnson & Johnson’s (JNJ) Dividend Growth Record Strengthens its Role in Dividend Paying Stocks
Yahoo Finance· 2025-09-21 03:25
公司业务与结构 - 公司是制药和医疗器械行业的主要参与者 近期市值接近4250亿美元[2] - 公司曾运营强大的消费者健康部门 生产泰诺和创可贴等知名产品 该部门于2023年分拆为独立公司Kenvue[3] 财务表现 - 第二季度收入同比增长5.8% 收益增长18%[2] - 季度股息为每股1.30美元 股息收益率为2.95%[5] 产品研发管线 - 产品组合包括免疫学治疗药物Stelara和Tremfya 以及癌症药物Darzalex和Erleada[4] - 拥有40个项目处于后期临床试验阶段 评估新候选药物并为现有治疗药物寻求额外批准[4] 股息记录 - 拥有63年股息增长记录 使其成为最佳派息股票之一[5] - 被列入12只最佳现时买入派息股票名单[1]
What Is Organizational Structure in a Business Plan?
Small Business Trends· 2025-09-20 13:31
Organizational structure in a business plan outlines how your company is arranged, defining roles, responsibilities, and reporting relationships. It’s crucial for establishing a clear hierarchy and departmentalization, which improve communication and decision-making. Comprehending different structures, such as centralized or decentralized models, can greatly impact operational efficiency. As you explore the various types of organizational structures, you’ll find that each offers unique benefits and challeng ...
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill
The Motley Fool· 2025-09-20 08:46
A high yield is only one part of the story when it comes to picking dividend stocks.It is tempting for a dividend investor to simply select the highest yielding stocks. The problem with that approach is that it exposes you to the risk of dividend cuts if the yield is too high for the company to support.Which is why dividend lovers also need to consider dividend history as they look at a company. And, when you do that, you'll find that companies like Pfizer (PFE -0.50%), which has a huge 7.2% yield, don't ma ...